Company profile: DCN Diagnostics
1.1 - Company Overview
Company description
- Provider of lateral flow diagnostics development and manufacturing services, offering contract assay development across lateral flow, flow-through, dry chemistry, and microfluidic formats; design and integration of custom point-of-use readers and lab-on-a-chip systems; scalable manufacturing from clinical trials to commercialization; user-friendly sample collection devices and cartridges; and visual/fluorescent labeling and reporting solutions.
Products and services
- Manufacturing: Produces scalable clinical-trial to commercialization batches via reel-to-reel modular LFA lines, with dry room and clean assembly, plus kitting and packaging
- Contract Assay Development: Engineers comprehensive assay programs for lateral flow, flow-through, dry chemistry, and microfluidic formats, tailored to specific diagnostic needs
- Custom Readers: Architects and integrates assays with point-of-use readers and lab-on-a-chip systems, spanning electronic, mechanical, optical, and software components
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DCN Diagnostics
CN Bio
HQ: United Kingdom
Website
- Description: Provider of human organ-on-a-chip platforms and services for drug discovery and disease research, including PhysioMimix OOC single- and multi-organ systems, PhysioMimix HT for higher-throughput R&D, contract research services, and liver and lung assays covering NASH, HBV, and COVID-19 for long-term culture, infection modeling, drug efficacy, safety testing, and immune response studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CN Bio company profile →
NanoCellect Biomedical
HQ: United States
Website
- Description: Provider of microfluidic cell analysis and sorting solutions, including WOLF G2 benchtop cell sorter with two lasers and up to nine colors for gentle bulk or single-cell workflows; VERLO image-guided sorter combining flow cytometry with image analysis for complex samples; N1 single-cell dispenser for 96-/384-well plates; CS1 chiller-stirrer for temperature control; and disposable, sterile microfluidic cartridges without cross-contamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoCellect Biomedical company profile →
CTT Pharmaceutical Holdings
HQ: Canada
Website
- Description: Provider of intraoral, quick-dissolving drug delivery systems, including thin film Dissolvable Strips for local/systemic absorption on the tongue, Med Strips for pain management and inflammation, and VetWAFE for pain management in pets. Also offers pharma partnering services with proprietary drug delivery technology to help bring products to market faster.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTT Pharmaceutical Holdings company profile →
OmniAb
HQ: United States
Website
- Description: Provider of antibody discovery technologies for next-generation therapeutics, offering the OmniAb Discovery Platform with diverse antibody repertoires and high-throughput screening via proprietary transgenic animals. Platforms include OmniRat, OmniMouse, and OmniChicken for fully human antibodies, and OmniFlic and OmniClic for bispecific antibodies using a common light chain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniAb company profile →
Avalon GloboCare
HQ: United States
Website
- Description: Provider of precision diagnostics and clinical lab services—including bloodwork, anatomic pathology, urine/drug toxicology, STAT blood and genetic testing, pharmacogenomic (PGx) testing via real-time PCR, and PCR COVID-19 testing—delivered via its Lab Services MSO. Also offers the FDA Class I KetoAir Breathalyzer for ketosis detection and the QTY protein design platform (joint IP with MIT) for water-soluble cytokine receptor variants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avalon GloboCare company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DCN Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DCN Diagnostics
2.2 - Growth funds investing in similar companies to DCN Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DCN Diagnostics
4.2 - Public trading comparable groups for DCN Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →